We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PPG Industries to Invest $15M in Application Support Center
Read MoreHide Full Article
PPG Industries Inc. (PPG - Free Report) recently announced an investment of $15 million in a new 3,600-square-meter application support center (ASC) at the Seletar Aerospace Park in Singapore. The ASC is slated for completion in first-quarter 2020.
The company stated that the ASC will accommodate higher demand for aerospace coatings and sealants, chemical management services and packaging of third-party products. The move is in response to the aerospace industry’s strong growth in Southeast Asia.
Moreover, the state-of-the-art facility will aid collaboration and enable the company in delivering efficient and value-added services to customers.
PPG Industries’ global aerospace business offerings include sealants, coatings, transparencies, application and packaging systems, and chemical management and other services.
PPG Industries, which is among the prominent players in the chemical space along with Eastman Chemical Company (EMN - Free Report) , Air Products and Chemicals, Inc. (APD - Free Report) and Celanese Corporation (CE - Free Report) , logged net income from continuing operations of $270 million or $1.13 per share in second-quarter 2019, down around 27% year over year.
Adjusted earnings per share were $1.85, down from $1.90 a year ago. However, it beat the Zacks Consensus Estimate of $1.83.
PPG Industries expects industry demand for several of its businesses to remain sluggish in the third quarter. The company remains focused on recovering operating margins and expects the momentum to continue as it works with customers and suppliers to mitigate the impact of raw material cost inflation further.
The company expects third-quarter earnings in the range of $1.57-$1.67 per share. It also reaffirmed 2019 adjusted earnings per share growth of 7-10% and envisions sales growth of a low-single-digit percentage for the full year, both excluding currency translation impacts.
The company continues to aggressively manage costs amid a challenging business environment. It delivered roughly $20 million of cost savings in the second quarter. PPG Industries also remains committed in its cash deployment with a focus on shareholder value creation over the long term.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
PPG Industries to Invest $15M in Application Support Center
PPG Industries Inc. (PPG - Free Report) recently announced an investment of $15 million in a new 3,600-square-meter application support center (ASC) at the Seletar Aerospace Park in Singapore. The ASC is slated for completion in first-quarter 2020.
The company stated that the ASC will accommodate higher demand for aerospace coatings and sealants, chemical management services and packaging of third-party products. The move is in response to the aerospace industry’s strong growth in Southeast Asia.
Moreover, the state-of-the-art facility will aid collaboration and enable the company in delivering efficient and value-added services to customers.
PPG Industries’ global aerospace business offerings include sealants, coatings, transparencies, application and packaging systems, and chemical management and other services.
PPG Industries, which is among the prominent players in the chemical space along with Eastman Chemical Company (EMN - Free Report) , Air Products and Chemicals, Inc. (APD - Free Report) and Celanese Corporation (CE - Free Report) , logged net income from continuing operations of $270 million or $1.13 per share in second-quarter 2019, down around 27% year over year.
Adjusted earnings per share were $1.85, down from $1.90 a year ago. However, it beat the Zacks Consensus Estimate of $1.83.
PPG Industries expects industry demand for several of its businesses to remain sluggish in the third quarter. The company remains focused on recovering operating margins and expects the momentum to continue as it works with customers and suppliers to mitigate the impact of raw material cost inflation further.
The company expects third-quarter earnings in the range of $1.57-$1.67 per share. It also reaffirmed 2019 adjusted earnings per share growth of 7-10% and envisions sales growth of a low-single-digit percentage for the full year, both excluding currency translation impacts.
The company continues to aggressively manage costs amid a challenging business environment. It delivered roughly $20 million of cost savings in the second quarter. PPG Industries also remains committed in its cash deployment with a focus on shareholder value creation over the long term.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>